Trademark: 88846941
Status Date
Monday, October 24, 2022
Filing Date
Wednesday, March 25, 2020
Published for Opposition
Tuesday, July 28, 2020
Abandoned Date
Monday, October 24, 2022
5 Pharmaceutical preparations and components thereof for treatment of infectious disease, namely, QTY-code designed cytokine and chemokine receptor protein variants with antibody-like properties used to trap cytokines, chemokines and inflammatory mediators released by immune effector cells during pathophysiological conditions, including but not limited to cytokine release syndrome associated with CAR-T therapy, Coronavirus-induced lung damage, and other such similar pathophysiological conditions
Oct 24, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 24, 2022
Abandonment - No Use Statement Filed
Feb 5, 2022
Notice Of Approval Of Extension Request E-Mailed
Feb 3, 2022
Sou Extension 3 Granted
Feb 3, 2022
Sou Extension 3 Filed
Feb 3, 2022
Teas Extension Received
Sep 24, 2021
Notice Of Approval Of Extension Request E-Mailed
Sep 22, 2021
Sou Extension 2 Granted
Sep 22, 2021
Sou Extension 2 Filed
Sep 22, 2021
Teas Extension Received
Feb 23, 2021
Notice Of Approval Of Extension Request E-Mailed
Feb 19, 2021
Sou Extension 1 Granted
Feb 19, 2021
Sou Extension 1 Filed
Feb 19, 2021
Teas Extension Received
Sep 22, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 28, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 28, 2020
Published For Opposition
Jul 8, 2020
Notification Of Notice Of Publication E-Mailed
Jun 21, 2020
Approved For Pub - Principal Register
Jun 16, 2020
Assigned To Examiner
Mar 30, 2020
New Application Office Supplied Data Entered In Tram
Mar 28, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
